Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis

• Autori principali: Yuan Li (Autore), Haicui Wu (Autore), Ying Guo (Autore), Chaofeng Wei (Autore), Lu Guan (Autore), Wenhan Ju (Autore), Fang Lian (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2023-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background/Aim Cangfu Daotan Wan (CFDTW) has been widely used for polycystic ovary syndrome (PCOS) patients in the type of stagnation of phlegm and dampness. In this study, we aimed to evaluate the mechanism underlying the therapeutic effect of CFDTW on PCOS with phlegm-dampness syndrome (P...